GOLEMBIEWSKI MICHAEL JOSEPH (Chief Financial Officer) received a stock award from SEELOS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/1/2024ACC: 0001104659-24-030070
Officer· Chief Financial Officer
Since Sep 2021
+417.00
Net shares
Net buyer
$457.45
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
417.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+417.00
Price / share
$1.10
Trade value
$457.45
% of position
0.5%
2/29/2024
86.45K→86.87K
Total
Net shares
+417.00
Net value
$457.45
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/29/2024 | A · Award | +417.00 | $1.10 | $457.45 | 0.5% | 86.45K | 86.87K |
| Total | +417.00 | $457.45 | ||||||
Derivative Transactions0
No derivative transactions reported